| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2B | $10.3B | $11.2B | $9.8B | $9.7B | $9.6B | $2.5B | $2.5B |
| Cost of Revenue | — | — | — | — | — | $3.1B | $3.4B | $3.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.0B | $2.4B | $3.7B | $1.4B | $-0.9B | $2.3B | $0.5B | $0.5B |
| Net Income | $2.1B | $1.8B | $2.6B | $1.0B | $-0.6B | $1.9B | $1.7B | $1.4B |
| EPS (Basic) | $4.23 | $3.56 | $5.15 | $2.07 | $-1.29 | $3.78 | $0.86 | $0.39 |
| EPS (Diluted) | $4.22 | $3.54 | $5.13 | $2.06 | $-1.29 | $3.76 | $0.86 | $0.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.6B | $54.6B | $50.7B | $48.7B | $49.0B | $50.0B | $47.7B | $45.3B |
| Current Assets | $4.6B | $4.2B | $3.4B | $4.3B | $6.3B | $3.6B | $3.2B | $3.5B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.5B | $0.8B | $0.5B | $0.1B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.7B | $6.5B | $5.1B | $6.7B | $7.1B | $5.5B | $5.0B | $4.9B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $2.1B | $3.8B | $1.5B | $1.7B | $3.1B | $3.4B | $2.9B |
| Investing Cash Flow | $-3.3B | $-3.3B | $-3.0B | $-1.1B | $-2.2B | $-2.7B | $-3.1B | $-3.9B |
| Capital Expenditures | $3.3B | $3.4B | $3.3B | $2.9B | $2.7B | $2.9B | $3.2B | $3.9B |
| Financing Cash Flow | $0.0B | $1.2B | $-1.3B | $-0.8B | $0.8B | $-0.0B | $-0.3B | $0.9B |